Sionna Therapeutics, Inc. (SION) stock
SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.07−0.05 (-1.60%)
Close on Nov 17, 2026Market cap $138.80MP/E –Yield –
Sionna Therapeutics cash
Cash and short-term investments held at the end of each period.
Sionna Therapeutics's cash was $249.80M at Sep 30, 2026. For fiscal 2025 it was $58.45M, up 50.8% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.45M | +50.8% |
| FY2024 | Dec 31, 2024 | $38.75M | -1.9% |
| FY2023 | Dec 31, 2023 | $39.48M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $249.80M | -23.1% |
| Q2 FY2026 | Jun 30, 2026 | $268.30M | -20.5% |
| Q1 FY2026 | Mar 31, 2026 | $289.90M | -18.3% |
| Q4 FY2025 | Dec 31, 2025 | $58.45M | +50.8% |
| Q3 FY2025 | Sep 30, 2025 | $325.00M | +809.1% |
| Q2 FY2025 | Jun 30, 2025 | $337.30M | +666.2% |
| Q1 FY2025 | Mar 31, 2025 | $354.70M | +328.6% |
| Q4 FY2024 | Dec 31, 2024 | $38.75M | -1.9% |
| Q3 FY2024 | Sep 30, 2024 | $35.75M | – |
| Q2 FY2024 | Jun 30, 2024 | $44.02M | – |
| Q1 FY2024 | Mar 31, 2024 | $82.75M | – |
| Q4 FY2023 | Dec 31, 2023 | $39.48M | – |
See a number that looks wrong?